ModelEdge
Moonlake Immunotherapeutics
MLTX
Filing type
8-K
Filing date
Jun 8, 2026
Updated
Jun 9, 2026 ยท 2:55 PM

Filing

8-KChanges in Board, Management or Compensation, Shareholder votes

Exhibits

EX-10.1MOONLAKE IMMUNOTHERAPEUTICS AMENDED AND RESTATED 2022 EQUITY INCENTIVE PLAN